Evidence map›Paper›PMID 36894905›Full record

ArticleBMC oral health2023

Oridonin alleviates the inhibitory effect of lipopolysaccharide on the proliferation and osteogenic potential of periodontal ligament stem cells by inhibiting endoplasmic reticulum stress and NF-κB/NLRP3 inflammasome signaling.

Junhao Jiang, Nong Zhang, Haibo Song, Ya Yang, Juan Li, Xiaoli Hu

Open access · goldAbstract read
In one paragraph

Article in BMC oral health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Junhao JiangDepartment of Stomatology, Shenzhen Longgang District Maternity & Child Healthcare Hospital(Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, China. jjhao2003@126.com.
Nong ZhangDepartment of Stomatology, Shenzhen Longgang District Maternity & Child Healthcare Hospital(Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, China.
Haibo SongDepartment of Stomatology, Shenzhen Longgang District Maternity & Child Healthcare Hospital(Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, China.
Ya YangDepartment of Stomatology, Shenzhen Longgang District Maternity & Child Healthcare Hospital(Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, China.
Juan LiDepartment of Stomatology, Shenzhen Longgang District Maternity & Child Healthcare Hospital(Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, China.
Xiaoli HuDepartment of Operative Dentistry and Endodontics, Guanghua School and Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, 510055, Guangdong, China. huxiaol3@mail.sysu.edu.cn.
Shantou University · CNShenzhen Maternity and Child Healthcare Hospital · CNStomatology Hospital · CN

Funding

Shenzhen Longgang District Science and Technology Development Fund LGKCYLWS2018000187
6 · The paper itself

Abstract

backgroundThe aim of this study was to investigate the protective effect and mechanism of oridonin in an in vitro lipopolysaccharide (LPS)-induced human periodontal ligament stem cells (hPDLSCs) model of periodontitis.

methodsPrimary hPDLSCs were isolated and cultured, and then the expression of surface antigens CD146, STRO-1 and CD45 of hPDLSCs was detected by flow cytometry. The mRNA expression level of Runx2, OPN, Col-1, GRP78, CHOP, ATF4 and ATF6 in the cells was tested by qRT-PCR. MTT was taken to determine the cytotoxicity of oridonin at different concentrations (0-4 μM) on hPDLSCs. Besides, ALP staining, alizarin red staining and Oil Red O staining were utilized to assess the osteogenic differentiation (ALP concentration, mineralized calcium nodule formation) and adipogenic differentiation abilities of the cells. The proinflammatory factors level in the cells was measured by ELISA. The protein expression level of NF-κB/NLRP3 pathway-related proteins and endoplasmic reticulum (ER) stress-related markers in the cells were detected by Western blot.

resultshPDLSCs with positive CD146 and STRO-1 expression and negative CD45 expression were successfully isolated in this study. 0.1-2 μM of oridonin had no significant cytotoxicity on the growth of hPDLSCs, while 2 μM of oridonin could not only greatly reduce the inhibitory effect of LPS on the proliferation and osteogenic differentiation of hPDLSCs cells, but also inhibit LPS-induced inflammation and ER stress in hPDLSCs cells. Moreover, further mechanism research showed that 2 μM of oridonin suppressed NF-κB/NLRP3 signaling pathway activity in LPS-induced hPDLSCs cells.

conclusionsOridonin promotes proliferation and osteogenic differentiation of LPS-induced hPDLSCs in an inflammatory environment, possibly by inhibiting ER stress and NF-κB/NLRP3 pathway. Oridonin may have a potential role in the repair and regeneration of hPDLSCs.

Indexed as

LipopolysaccharidesNF-kappa BCD146 AntigenCell DifferentiationCell ProliferationCells, CulturedHumansInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinOsteogenesisPeriodontal LigamentSignal TransductionStem CellsCD146 AntigenInflammasomesLipopolysaccharidesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinEndoplasmic reticulum (ER) stressHuman periodontal ligament stem cells (hPDLSCs)NF-κB/NLRP3 inflammasomeOridoninOsteogenic potential

Identifiers

PMID36894905
PMCPMC9999511
OpenAlexW4323808405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.